GLP-1 Weight Loss: Experts Advise Tracking Body Composition and Boosting Protein
GLP-1 receptor agonists can lead to significant weight loss, but studies indicate that 15% to 40% of the lost weight may come from lean body mass. Clinicians are using body composition analysis to monitor patients and recommend increased protein intake and resistance training to preserve muscle. Experts emphasize that the goal should be improving body composition and metabolic health, not just losing weight.
The article reports that GLP-1 medications can produce weight loss up to 20%, but a significant portion—estimated between 15% and 40%—may come from lean tissue rather than fat. Clinicians are increasingly using bioelectrical impedance scales to monitor fat mass, skeletal muscle, and visceral fat, with monthly scans during active weight loss and less frequent checks during maintenance phases.
Nutritional guidance centers on a daily protein target of 1.2 to 1.6 grams per kilogram of body weight, with protein prioritized at meals since appetite suppression makes eating difficult. Resistance training is considered essential, with recommendations of at least two sessions weekly, progressing toward 90 minutes using progressive overload. One study showed semaglutide users lost more lean mass than diet-only participants, but higher protein intake reduced that loss.
This story could reshape how patients and doctors approach weight management, shifting focus from scale numbers to body composition quality. Patients using GLP-1 drugs may need more nutritional guidance and exercise support than previously offered, potentially affecting how clinics structure obesity care. Long-term health outcomes could improve if muscle preservation becomes standard practice, though access to body composition monitoring may vary across healthcare settings.